GB0917072D0 - Peptide analogues of glucagon for diabetes therapy - Google Patents

Peptide analogues of glucagon for diabetes therapy

Info

Publication number: GB0917072D0
Authority: GB; United Kingdom
Prior art keywords: glucagon; peptide analogues; diabetes therapy; diabetes; therapy
Prior art date: 2009-09-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ulster University

Original Assignee

Ulster University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-09-29Application filed by Ulster UniversityfiledCriticalUlster University

2009-09-29Priority to GB0917072ApriorityCriticalpatent/GB0917072D0/en

2009-11-11Publication of GB0917072D0publicationCriticalpatent/GB0917072D0/en

2010-09-29Priority to PCT/EP2010/005943prioritypatent/WO2011038900A2/en

StatusCeasedlegal-statusCriticalCurrent

Links

206010012601diabetes mellitusDiseases0.000title1
MASNOZXLGMXCHN-ZLPAWPGGSA-NglucagonChemical classC([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1MASNOZXLGMXCHN-ZLPAWPGGSA-N0.000title1
108090000765processed proteins & peptidesProteins0.000title1
238000002560therapeutic procedureMethods0.000title1

GB0917072A2009-09-292009-09-29Peptide analogues of glucagon for diabetes therapyCeasedGB0917072D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GB0917072AGB0917072D0 (en)	2009-09-29	2009-09-29	Peptide analogues of glucagon for diabetes therapy
PCT/EP2010/005943WO2011038900A2 (en)	2009-09-29	2010-09-29	Peptide analogues of glucagon for diabetes therapy

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0917072AGB0917072D0 (en)	2009-09-29	2009-09-29	Peptide analogues of glucagon for diabetes therapy

Publications (1)

Publication Number	Publication Date
GB0917072D0true GB0917072D0 (en)	2009-11-11

Family

ID=41350545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0917072ACeasedGB0917072D0 (en)	2009-09-29	2009-09-29	Peptide analogues of glucagon for diabetes therapy

Country Status (2)

Country	Link
GB (1)	GB0917072D0 (en)
WO (1)	WO2011038900A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8541368B2 (en)*	2011-09-23	2013-09-24	Novo Nordisk A/S	Glucagon analogues
GB201214493D0 (en)*	2012-08-14	2012-09-26	Univ Ulster	Therapies
RS59124B1 (en)	2013-04-18	2019-09-30	Novo Nordisk As	Stable, protracted glp-1/glucagon receptor co-agonists for medical use
EP3151852A1 (en)	2014-06-04	2017-04-12	Novo Nordisk A/S	Glp-1/glucagon receptor co-agonists for medical use
US20160151511A1 (en)	2014-12-02	2016-06-02	Antriabio, Inc.	Proteins and protein conjugates with increased hydrophobicity
PE20171154A1 (en)	2014-12-30	2017-08-16	Hanmi Pharm Ind Co Ltd	GLUCAGON DERIVATIVES WITH IMPROVED STABILITY
JOP20200119A1 (en)*	2015-01-09	2017-06-16	Lilly Co Eli	Gip and glp-1 co-agonist compounds
AU2016270302B2 (en)	2015-06-04	2020-09-17	Rezolute, Inc.	Amine pegylation methods for the preparation of site-specific protein conjugates
PE20180449A1 (en)	2015-06-30	2018-03-05	Hanmi Pharm Ind Co Ltd	DERIVATIVE OF GLUCAGON AND A COMPOSITION THAT INCLUDES A CONJUGATE OF PROLONGED ACTION OF THE SAME
CN115920077B (en)	2015-12-31	2025-07-04	韩美药品株式会社	Long-acting conjugate of glucagon/GLP-1/GIP receptor triple agonist
KR102005457B1 (en)	2016-06-29	2019-07-30	한미약품 주식회사	glucagon derivative, a conjugate thereof, and a composition comprising the same, and a therapeutic use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5480867A (en)*	1993-12-29	1996-01-02	The Rockefeller University	Glucagon analogs with serine replacements
US6677136B2 (en)*	2000-05-03	2004-01-13	Amgen Inc.	Glucagon antagonists
AR036711A1 (en)	2001-10-05	2004-09-29	Bayer Corp	PEPTIDES THAT ACT AS GLON-RECEPTOR AGONISTS AND AS GLUCAGON RECEPTOR ANTAGONISTS AND THEIR PHARMACOLOGICAL USE METHODS
WO2004007524A2 (en)	2002-07-17	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic oligopeptides
US20050124550A1 (en)*	2003-06-18	2005-06-09	Peri Krishna G.	Compounds that modulate the glucagon response and uses thereof
DK2084182T3 (en)	2006-10-03	2013-11-04	Cadila Healthcare Ltd	ANTIDIABETIC RELATIONS
EP2214691B1 (en)*	2007-10-30	2015-09-30	Indiana University Research and Technology Corporation	Compounds exhibiting glucagon antagonist and glp-1 agonist activity
WO2009058662A2 (en)*	2007-10-30	2009-05-07	Indiana University Research And Technology Corporation	Glucagon antagonists

2009
- 2009-09-29GBGB0917072Apatent/GB0917072D0/ennot_activeCeased
2010
- 2010-09-29WOPCT/EP2010/005943patent/WO2011038900A2/enactiveApplication Filing

Also Published As

Publication number	Publication date
WO2011038900A2 (en)	2011-04-07
WO2011038900A3 (en)	2011-06-23

Similar Documents

Publication	Publication Date	Title
GB0917072D0 (en)	2009-11-11	Peptide analogues of glucagon for diabetes therapy
AP3286A (en)	2015-05-31	Glucagon analogues
EP2328922A4 (en)	2013-01-02	Analogues of glucose-dependent insulinotropic polypeptide
ZA201206838B (en)	2013-06-26	Novel glucagon analogues
AP2013006671A0 (en)	2013-01-31	Glucagon analogues
IL252058A0 (en)	2017-07-31	Peptide analogs of alpha-melanocyte stimulating hormone
AP3329A (en)	2015-06-30	Acylated glucagon analogues
ZA201104592B (en)	2013-11-27	Glucagon analogues
ZA201104593B (en)	2015-01-28	Glucagon analogues
ZA201104591B (en)	2014-11-26	Glucagon analogues
IL213477A0 (en)	2011-07-31	Glucagon analogues
EP2320923A4 (en)	2012-07-18	Truncated analogues of glucose-dependent insulinotropic polypeptide
IL222778A0 (en)	2012-12-31	Diabetes therapy
IL231199A0 (en)	2014-04-30	Novel glucagon analogues
EP2323678A4 (en)	2013-06-12	Glucose-dependent insulinotropic polypeptide analogues
ZA201306514B (en)	2014-05-28	Novel glucagon analogues
PL2496596T3 (en)	2017-08-31	Therapeutic peptides
ZA201204308B (en)	2013-08-28	Insulin analogues with chlorinated amino acids
EP2576612A4 (en)	2014-07-09	Insulin analogues
IL215245A0 (en)	2011-12-29	Use of nkp46 for preventing diabetes
ZA201003844B (en)	2011-03-30	Delivery of functional compounds
ZA201007911B (en)	2012-02-29	Processes for refolding of insulin
GB2468757B (en)	2014-08-20	Method of screening a drug such as insulin secretagogue
EP2739303A4 (en)	2015-03-25	A novel method for peroral delivery of insulin and its analogues for therapeutic usage
GB0919603D0 (en)	2009-12-23	Use of thymosin beta-4 for treatment of type II diabetes

Legal Events

Date	Code	Title	Description
2011-03-30	AT	Applications terminated before publication under section 16(1)

Movatterモバイル変換

GB0917072D0 - Peptide analogues of glucagon for diabetes therapy - Google Patents

Info

Links

Priority Applications (2)

Applications Claiming Priority (1)

Publications (1)

Family

ID=41350545

Family Applications (1)

Country Status (2)

Families Citing this family (11)

Family Cites Families (8)

Also Published As

Similar Documents

Legal Events